Vaccines for smallpox through of HERA (European Emergency Preparedness and Response Authority) The European Union is going to buy.
HERA will buy vaccines on behalf of the Member States (at the expense of the authority itself), but also vice versa, through the joint procurement procedure.
It should be noted, however, that the quantities of vaccines for each country.
Outbreaks appear to be exacerbated during childhood and adolescence is less than 200 worldwide, however, many are concerned about the availability and availability of drugs and vaccines for this disease. But drugs and vaccines are available, said the Health Policy professor Elias Mosialos, School of Economics and Political Science (LSE) and Imperial College London.
Regarding vaccination, he pointed out that there is a vaccine to protect against aphids in adults, whose efficiency is estimated at 85%. Vaccination is effective even after exposure to monkey pox virus. However, the sooner an exposed person gets the vaccine, the better. US and British health authorities (CDC and UKHSA) recommend that the vaccine be given within four days of exposure to prevent the onset of the disease. If given between 4-14 days after exposure, the vaccine reduces the symptoms, but usually can not prevent the disease.
The vaccine (MVA-BN) was also approved for use in the European Union in 2013 under the name Imvanex, for active immunization against smallpox in adults. Available in the US as JYNNEOS and received since September 2019 FDA approval for the prevention of smallpox and monkeys. However, this vaccine will be available in 2023 and the US Biomedical Advanced Research and Development Authority has already secured 13 million doses. Something similar, as he states, should be done immediately by the European Union through the European Authority for Emergency Preparedness and Response to Health.
Follow Skai.gr on Google News
and be the first to know all the news
